🇺🇸 FDA
Patent

US 9528994

Target of the phosphoinositide 3-kinase pathway

granted A61PA61P35/00

Quick answer

US patent 9528994 (Target of the phosphoinositide 3-kinase pathway) held by The Regents of the University of California expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00